JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cenacchi, G
Right arrow Articles by Angelini, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cenacchi, G
Right arrow Articles by Angelini, C
Journal of Clinical Pathology 2005;58:190-195
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


ORIGINAL ARTICLE

Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism

G Cenacchi1, M Fanin2, L B De Giorgi1, C Angelini2

1 Clinical Department of Radiological and Histocytopathological Sciences, University of Bologna, 40138 Bologna, Italy
2 Neuroscience Department, University of Padova, and Venetian Institute of Molecular Medicine, 35128 Padova, Italy

Correspondence to:
Professor C Angelini
Department of Neurosciences, University of Padova, via Giustiniani 5, 35128 Padova, Italy; corrado.angelini{at}unipd.it Background: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process. Dysferlin is known to play an essential role in skeletal muscle fibre repair, but the process underlying the pathogenetic mechanism of dysferlinopathy is not completely understood.

Aims: To define both specific alterations of muscle fibres and a possible sequential mechanism of myopathy development.

Methods: A histological, immunohistochemical, and ultrastructural analysis of 10 muscle biopsies from patients with molecularly diagnosed dysferlinopathy.

Results: An inflammatory response was seen in most of the muscle biopsies. The immunohistochemical pattern demonstrated active regeneration and inflammation. Non-necrotic fibres showed alterations at different submicroscopic levels, namely: the sarcolemma and basal lamina, subsarcolemmal region, and sarcoplasmic compartment. In the subsarcolemmal region there were prominent aggregations of small vesicles, probably derived from the Golgi apparatus, which consisted of empty, swollen cisternae. In the sarcolemma there were many gaps and microvilli-like projections, whereas the basal lamina was multilayered.

Conclusions: The histopathological, immunohistochemical, and ultrastructural data show that dysferlinopathy is characterised by a very active inflammatory/degenerative process, possibly associated with an inefficient repair and regenerative system. The presence of many crowded vesicles just beneath the sarcolemma provides submicroscopical proof of a defective resealing mechanism, which fails to repair the sarcolemma.


Abbreviations: LGMD, limb girdle muscular dystrophy; MHC, major histocompatibility class; MM, Miyoshi myopathy




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. Spinazzi, S. Cazzola, M. Bortolozzi, A. Baracca, E. Loro, A. Casarin, G. Solaini, G. Sgarbi, G. Casalena, G. Cenacchi, et al.
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function
Hum. Mol. Genet., November 1, 2008; 17(21): 3291 - 3302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Nagaraju, R. Rawat, E. Veszelovszky, R. Thapliyal, A. Kesari, S. Sparks, N. Raben, P. Plotz, and E. P. Hoffman
Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B
Am. J. Pathol., March 1, 2008; 172(3): 774 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. N. Bernatchez, L. Acevedo, C. Fernandez-Hernando, T. Murata, C. Chalouni, J. Kim, H. Erdjument-Bromage, V. Shah, J.-P. Gratton, E. M. McNally, et al.
Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function
J. Biol. Chem., October 19, 2007; 282(42): 30745 - 30753.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Nguyen, G. Bassez, M. Krahn, R. Bernard, P. Laforet, V. Labelle, J. A. Urtizberea, D. Figarella-Branger, N. Romero, S. Attarian, et al.
Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes
Arch Neurol, August 1, 2007; 64(8): 1176 - 1182.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. G. Tidball and M. Wehling-Henricks
Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo
J. Physiol., January 1, 2007; 578(1): 327 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. L. Washington and S. Ward
FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis
J. Cell Sci., June 15, 2006; 119(12): 2552 - 2562.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. R. Doherty, A. Cave, D. B. Davis, A. J. Delmonte, A. Posey, J. U. Earley, M. Hadhazy, and E. M. McNally
Normal myoblast fusion requires myoferlin
Development, December 15, 2005; 132(24): 5565 - 5575.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.